Genetics of risk factors for melanoma: An adult twin study of nevi and freckles

Journal of the National Cancer Institute

Volumn 92, Issue 6, 2000, Pages 457-463

  Bataille, Veronique ^a,c   Snieder, Harold ^d   MacGregor, Alex J ^d   Sasieni, Peter ^b   Spector, Tim D ^d  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; FEMALE; GENETIC RISK; HEREDITY; HUMAN; LENTIGO; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; QUANTITATIVE GENETICS; RISK ASSESSMENT; TWINS;

EID: 0034653681     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.6.457     Document Type: Article

References (45)

1. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994; 19/ 20:219-40.
2. Koh HK, Kliger BE, Lew RA. Yearly review. Sunlight and cutaneous malignant melanoma: evidence for and against causation. Photochem Photobiol 1990;6:765-79.
3. Healy E, Belgaid C, Takata M, Harrison D, Zhu NW, Burd DA, et al. Prognostic significance of allelic losses in primary melanoma. Oncogene 1998;16:2213-8.
4. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, et al. Germline p16 mutations in familial melanoma. Nat Genet 1994;8:15-21.
5. Harland M, Meloni R, Gruis N, Pinney E, Brookes S, Spurr N, et al. Germline mutations of the CDKN2 gene in UK melanoma families. Hum Mol Genet 1997;6:2061-7.
6. Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, et al. Prevalence of p16 and CDK4 germline mutations in 48 melanoma prone families in France. The French Familial Melanoma Study Group. Hum Mol Genet 1998;7:209-16.
7. Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A, et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 1995;10:351-3.
8. Walker GJ, Hussussian CJ, Flores JF, Glendening JM, Haluska FG, Dracopoli NC, et al. Mutations in the CDKN2/p16INK4 gene in Australian melanoma kindreds. Hum Mol Genet 1995;4:1845-52.
9. Holland EA, Beaton SC, Becker TM, Grulet OM, Peters BA, Rizos H, et al. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene 1995;2289-94.
10. Osterlind A, Tucker MA, Stone BJ, Jensen OM. The Danish case control study of cutaneous malignant melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. Int J Cancer 1988;42: 825-8.
11. Green AC, Bain C, McLennan R, Siskind V. Risk factors for cutaneous melanoma in Queensland. Recent Res Cancer Res 1986;102:76-97.
12. Augustsson A, Stierner U, Suurkula M, Rosdahl. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Derm Venereol (Stockh) 1991;71:518-24.
13. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17:459-68.
14. Grulich A, Bataille V, Swerdlow A, McCarthy W, Hersey P, McCarthy WH, et al. A case-control study of melanoma in New South Wales, Australia. Int J Cancer 1996;67:485-91.
15. Bataille V, Newton Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, et al. Risk of cutaneous melanoma in relation to the numbers, types, sites of naevi. A case-control study. Br J Cancer 1996;73:1605-11.
16. Grob JJ, Gouvernet J, Aymar D, Mostaque A, Romano MH, Collet AM, et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular, superficial spreading melanoma. Cancer 1990;66: 387-95.
17. Greene MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fraser MC. High risk of malignant melanoma in melanoma-prone families with dysplastic naevi. Ann Intern Med 1985;102:458-65.
18. Newton Bishop JA, Bataille V, Pinney E, Bishop DT. Family studies in melanoma: identification of the Atypical Mole Syndrome (AMS) phenotype. Melanoma Res 1994;4:199-206.
19. MacKie RM, McHenry P, Hole D. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high risk groups. Lancet 1993;341:1618-20.
20. Clark WH, Reimer RR, Greene M, Ainsworth AM, Masrangelo MJ. Origin of familial malignant melanoma from heritable melanocytic lesions: the BK mole syndrome. Arch Dermatol 1978;114:732.
21. Lynch HT, Frichot BC, Lynch JF. Familial atypical multiple mole melanoma syndrome. J Med Genet 1978;15:352-6.
22. Wachsmuth R, Harland M, Newton Bishop JA. The atypical mole syndrome phenotype is a poor predictor of predisposition in melanoma families. N Engl J Med 1998;339:348-9.
23. Gruis NA, Sandkuijl LA, van der Velden PA, Bergman W. CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families. Melanoma Res 1995;5: 169-77.
24. Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995;33:1000-7.
25. Bliss JM, Ford D, Swerdlow AJ, Armstrong BK, Cristofolini M, Elwood JM, et al. Risk of cutaneous melanoma associated with pigmentation characteristics, freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995;9: 367-76.
26. Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE et al. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 1994;30:40-8.
27. Harrison SL, MacLenna R, Speare R, Wronski I. Sun exposure, melanocytic naevi in young Australian children. Lancet 1994;344:1529-32.
28. Bataille V, Grulich A, Sasieni P, Newton Bishop J, McCarthy W, Hersey P, et al. The association between number of naevi, melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK, Australia. Br J Cancer 1998;77:505-10.
29. Martin N, Boomsma D, Martin G. A twin-pronged attack on complex traits. Nat Genet 1997;17:387-92.
30. Fitzpatrick TB, Miyamoto M, Ishikawa K. The evolution of concepts of melanin biology. Arch Dermatol 1967;96:305-23.
31. Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HK, Spinelli JJ, et al. Suntan, sunburn, pigmentation factors, the frequency of acquired melanocytic nevi in children: similarities to melanoma. The Vancouver Mole Study. Arch Dermatol 1990;126:770-6.
32. Falconer DS. Introduction to quantitative genetics. 3rd ed. Harlow (U.K.): Longman; 1989.
33. Neale MC. Mx: Statistical modeling. Box 710 MCV, Richmond, VA 23298: Department of Psychiatry. 2nd edition; 1997.
34. Neale MC, Cardon LR. Methodology for genetic studies in twins, families. Dordrecht (Germany): Kluwer Academic Publishers; 1992.
35. Siemens HW. Die Zwillingspathologie. Ihre Bedeutung, Ihre Methodik, Ihre bisherigen Ergebnisse. Berlin (Germany): Julius Springer; 1924.
36. Duffy DL, MacDonald AM, Easton DF, Ponder BA, Martin NG. Is the genetics of moliness simply the genetics of sun exposure? A path analysis of nevus counts, risk factors in twins. Cytogenet Cell Genet 1992;59:194-6.
37. Box NF, Wyeth JR, O'Gorman LE, Martin NG, Sturn RA. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 1997;6:1891-7.
38. Valverde P, Healy E, Sikkink S, Haldane F, Thody AJ, Carothers A, et al. The Asp84-Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 1996;5:1663-6.
39. McConnell BB, Starborg M, Brookes S, Peters G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol 1998;8:351-4.
40. Briollais L, Chompret A, Guilloud-Bataille M, Feingold N, Avril MF, Demenais F. Genetic, epidemiological risk factors for a malignant melanoma predisposing phenotype: the great number of nevi. Gen Epidemiol 1996;13:385-402.
41. Platz A, Hansson J, Ringborg U. Screening of germline mutations in the CDK4, CDKN2C, TP53 genes in familial melanoma. A clinic-based population study. Int J Cancer 1998;78:13-5.
42. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE, et al. Loss of alleles from the distal arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 1989;86:4614-8.
43. Healy E, Belgaid CE, Takata M, Vahlquist A, Rehman I, Rigby H, et al. Allelotypes of primary cutaneous melanoma, benign melanocytic naevi. Cancer Res 1996;56:589-93.
44. Flores JF, Pollack PM, Walker JG, Glendening JM, Lin AH, Palmer MK, et al. Analysis of the CDKN2A, CDKN2B, CDK4 genes in 48 Australian melanoma kindreds. Oncogene 1997;15:2999-3005.
45. Snieder H, Boomsma DI, van Doornen LJ, de Geus EJ. Heritability of respiratory sinus arrhythmia: dependency on task and respiration rate. Psychophysiology 1997;34:317-28